Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function

The structural basis of normoalbuminuric renal insufficiency in patients with type 2 diabetes remains to be elucidated. We compared renal biopsy findings in patients with type 2 diabetes and estimated glomerular filtration rate (eGFR) and measured GFR of <60 mL/min/1.73 m2, associated with either...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 36; no. 11; pp. 3620 - 3626
Main Authors Ekinci, Elif I., Jerums, George, Skene, Alison, Crammer, Paul, Power, David, Cheong, Karey Y., Panagiotopoulos, Sianna, McNeil, Karen, Baker, Scott T., Fioretto, Paola, MacIsaac, Richard J.
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.11.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The structural basis of normoalbuminuric renal insufficiency in patients with type 2 diabetes remains to be elucidated. We compared renal biopsy findings in patients with type 2 diabetes and estimated glomerular filtration rate (eGFR) and measured GFR of <60 mL/min/1.73 m2, associated with either normo-, micro-, or macroalbuminuria. In patients with normo- (n = 8) or microalbuminuria (n = 6), renal biopsies were performed according to a research protocol. In patients with macroalbuminuria (n = 17), biopsies were performed according to clinical indication. Findings were categorized according to the Fioretto classification: category 1 (C1), normal/near normal; category 2 (C2), typical diabetic nephropathy (DN) with predominantly glomerular changes; and category 3 (C3), atypical with disproportionately severe interstitial/tubular/vascular damage and with no/mild diabetic glomerular changes. In our study population (mean eGFR 35 mL/min/1.73 m2), typical glomerular changes (C2) of DN were observed in 22 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 subjects with normoalbuminuria (P = 0.002). By contrast, predominantly interstitial or vascular changes (C3) were seen in only 1 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 normoalbuminuric subjects (P = 0.08). Mesangial area increased progressively from normal controls to patients with type 2 diabetes and normo-, micro-, and macroalbuminuria. Varying degrees of arteriosclerosis, although not necessarily the predominant pattern, were seen in seven of eight subjects with normoalbuminuria. Typical renal structural changes of DN were observed in patients with type 2 diabetes and elevated albuminuria. By contrast, in normoalbuminuric renal insufficiency, these changes were seen less frequently, likely reflecting greater contributions from aging, hypertension, and arteriosclerosis.
AbstractList The structural basis of normoalbuminuric renal insufficiency in patients with type 2 diabetes remains to be elucidated. We compared renal biopsy findings in patients with type 2 diabetes and estimated glomerular filtration rate (eGFR) and measured GFR of <60 mL/min/1.73 m , associated with either normo-, micro-, or macroalbuminuria. In patients with normo- (n = 8) or microalbuminuria (n = 6), renal biopsies were performed according to a research protocol. In patients with macroalbuminuria (n = 17), biopsies were performed according to clinical indication. Findings were categorized according to the Fioretto classification: category 1 (C1), normal/near normal; category 2 (C2), typical diabetic nephropathy (DN) with predominantly glomerular changes; and category 3 (C3), atypical with disproportionately severe interstitial/tubular/vascular damage and with no/mild diabetic glomerular changes In our study population (mean eGFR 35 mL/min/1.73 m ), typical glomerular changes (C2) of DN were observed in 22 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 subjects with normoalbuminuria (P = 0.002). By contrast, predominantly interstitial or vascular changes (C3) were seen in only 1 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 normoalbuminuric subjects (P = 0.08). Mesangial area increased progressively from normal controls to patients with type 2 diabetes and normo-, micro-, and macroalbuminuria. Varying degrees of arteriosclerosis, although not necessarily the predominant pattern, were seen in seven of eight subjects with normoalbuminuria. Typical renal structural changes of DN were observed in patients with type 2 diabetes and elevated albuminuria. By contrast, in normoalbuminuric renal insufficiency, these changes were seen less frequently, likely reflecting greater contributions from aging, hypertension, and arteriosclerosis.
The structural basis of normoalbuminuric renal insufficiency in patients with type 2 diabetes remains to be elucidated. We compared renal biopsy findings in patients with type 2 diabetes and estimated glomerular filtration rate (eGFR) and measured GFR of <60 mL/min/1.73 m2, associated with either normo-, micro-, or macroalbuminuria. In patients with normo- (n = 8) or microalbuminuria (n = 6), renal biopsies were performed according to a research protocol. In patients with macroalbuminuria (n = 17), biopsies were performed according to clinical indication. Findings were categorized according to the Fioretto classification: category 1 (C1), normal/near normal; category 2 (C2), typical diabetic nephropathy (DN) with predominantly glomerular changes; and category 3 (C3), atypical with disproportionately severe interstitial/tubular/vascular damage and with no/mild diabetic glomerular changes. In our study population (mean eGFR 35 mL/min/1.73 m2), typical glomerular changes (C2) of DN were observed in 22 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 subjects with normoalbuminuria (P = 0.002). By contrast, predominantly interstitial or vascular changes (C3) were seen in only 1 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 normoalbuminuric subjects (P = 0.08). Mesangial area increased progressively from normal controls to patients with type 2 diabetes and normo-, micro-, and macroalbuminuria. Varying degrees of arteriosclerosis, although not necessarily the predominant pattern, were seen in seven of eight subjects with normoalbuminuria. Typical renal structural changes of DN were observed in patients with type 2 diabetes and elevated albuminuria. By contrast, in normoalbuminuric renal insufficiency, these changes were seen less frequently, likely reflecting greater contributions from aging, hypertension, and arteriosclerosis.
The structural basis of normoalbuminuric renal insufficiency in patients with type 2 diabetes remains to be elucidated. We compared renal biopsy findings in patients with type 2 diabetes and estimated glomerular filtration rate (eGFR) and measured GFR of <60 mL/min/1.73 m2, associated with either normo-, micro-, or macroalbuminuria.OBJECTIVEThe structural basis of normoalbuminuric renal insufficiency in patients with type 2 diabetes remains to be elucidated. We compared renal biopsy findings in patients with type 2 diabetes and estimated glomerular filtration rate (eGFR) and measured GFR of <60 mL/min/1.73 m2, associated with either normo-, micro-, or macroalbuminuria.In patients with normo- (n = 8) or microalbuminuria (n = 6), renal biopsies were performed according to a research protocol. In patients with macroalbuminuria (n = 17), biopsies were performed according to clinical indication. Findings were categorized according to the Fioretto classification: category 1 (C1), normal/near normal; category 2 (C2), typical diabetic nephropathy (DN) with predominantly glomerular changes; and category 3 (C3), atypical with disproportionately severe interstitial/tubular/vascular damage and with no/mild diabetic glomerular changes.RESEARCH DESIGN AND METHODSIn patients with normo- (n = 8) or microalbuminuria (n = 6), renal biopsies were performed according to a research protocol. In patients with macroalbuminuria (n = 17), biopsies were performed according to clinical indication. Findings were categorized according to the Fioretto classification: category 1 (C1), normal/near normal; category 2 (C2), typical diabetic nephropathy (DN) with predominantly glomerular changes; and category 3 (C3), atypical with disproportionately severe interstitial/tubular/vascular damage and with no/mild diabetic glomerular changes.In our study population (mean eGFR 35 mL/min/1.73 m2), typical glomerular changes (C2) of DN were observed in 22 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 subjects with normoalbuminuria (P = 0.002). By contrast, predominantly interstitial or vascular changes (C3) were seen in only 1 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 normoalbuminuric subjects (P = 0.08). Mesangial area increased progressively from normal controls to patients with type 2 diabetes and normo-, micro-, and macroalbuminuria. Varying degrees of arteriosclerosis, although not necessarily the predominant pattern, were seen in seven of eight subjects with normoalbuminuria.RESULTSIn our study population (mean eGFR 35 mL/min/1.73 m2), typical glomerular changes (C2) of DN were observed in 22 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 subjects with normoalbuminuria (P = 0.002). By contrast, predominantly interstitial or vascular changes (C3) were seen in only 1 of 23 subjects with micro- or macroalbuminuria compared with 3 of 8 normoalbuminuric subjects (P = 0.08). Mesangial area increased progressively from normal controls to patients with type 2 diabetes and normo-, micro-, and macroalbuminuria. Varying degrees of arteriosclerosis, although not necessarily the predominant pattern, were seen in seven of eight subjects with normoalbuminuria.Typical renal structural changes of DN were observed in patients with type 2 diabetes and elevated albuminuria. By contrast, in normoalbuminuric renal insufficiency, these changes were seen less frequently, likely reflecting greater contributions from aging, hypertension, and arteriosclerosis.CONCLUSIONSTypical renal structural changes of DN were observed in patients with type 2 diabetes and elevated albuminuria. By contrast, in normoalbuminuric renal insufficiency, these changes were seen less frequently, likely reflecting greater contributions from aging, hypertension, and arteriosclerosis.
Audience Professional
Author Skene, Alison
Panagiotopoulos, Sianna
McNeil, Karen
Power, David
Fioretto, Paola
MacIsaac, Richard J.
Crammer, Paul
Cheong, Karey Y.
Baker, Scott T.
Ekinci, Elif I.
Jerums, George
Author_xml – sequence: 1
  givenname: Elif I.
  surname: Ekinci
  fullname: Ekinci, Elif I.
  organization: Endocrine Centre, Austin Health, Melbourne, Victoria, Australia, Department of Medicine, Austin Health, University of Melbourne, Melbourne, Victoria, Australia, Menzies School of Health Research, Darwin, Northern Territory, Australia
– sequence: 2
  givenname: George
  surname: Jerums
  fullname: Jerums, George
  organization: Endocrine Centre, Austin Health, Melbourne, Victoria, Australia, Department of Medicine, Austin Health, University of Melbourne, Melbourne, Victoria, Australia
– sequence: 3
  givenname: Alison
  surname: Skene
  fullname: Skene, Alison
  organization: Anatomical Pathology, Austin Health, Melbourne, Victoria, Australia
– sequence: 4
  givenname: Paul
  surname: Crammer
  fullname: Crammer, Paul
  organization: Anatomical Pathology, Southern Health, Melbourne, Victoria, Australia
– sequence: 5
  givenname: David
  surname: Power
  fullname: Power, David
  organization: Department of Medicine, Austin Health, University of Melbourne, Melbourne, Victoria, Australia, Department of Nephrology, Austin Health, Melbourne, Victoria, Australia
– sequence: 6
  givenname: Karey Y.
  surname: Cheong
  fullname: Cheong, Karey Y.
  organization: Endocrine Centre, Austin Health, Melbourne, Victoria, Australia
– sequence: 7
  givenname: Sianna
  surname: Panagiotopoulos
  fullname: Panagiotopoulos, Sianna
  organization: Endocrine Centre, Austin Health, Melbourne, Victoria, Australia
– sequence: 8
  givenname: Karen
  surname: McNeil
  fullname: McNeil, Karen
  organization: Endocrine Centre, Austin Health, Melbourne, Victoria, Australia
– sequence: 9
  givenname: Scott T.
  surname: Baker
  fullname: Baker, Scott T.
  organization: Endocrine Centre, Austin Health, Melbourne, Victoria, Australia, Department of Medicine, Austin Health, University of Melbourne, Melbourne, Victoria, Australia
– sequence: 10
  givenname: Paola
  surname: Fioretto
  fullname: Fioretto, Paola
  organization: Department of Internal Medicine, University of Padova, Padova, Italy
– sequence: 11
  givenname: Richard J.
  surname: MacIsaac
  fullname: MacIsaac, Richard J.
  organization: Department of Endocrinology and Diabetes, St. Vincent’s Health Fitzroy and University of Melbourne, Melbourne, Victoria, Australia
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27860598$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23835690$$D View this record in MEDLINE/PubMed
BookMark eNptkl1rFDEUhoNU7LZ64R-QARH0Ytp8ziQ3haVaLRQVrXgZMpkz25SZZE1mhP57M921Xyy5CEme856PvAdozwcPCL0m-IgyVh-3ltCSipo-QwuimCiF4HIPLTDhqhRK0X10kNI1xphzKV-gfcokE5XCCzT8AG_64ucYJztOEQrni68hDsH0zTQ4P0VnC-PbYvng_N2MDvyYit9uvCoub9ZQ0OKjMw2MkG7p82FtXIS22MifTd6OLviX6Hln-gSvtvsh-nX26fL0S3nx7fP56fKitILJsbSykpRDzWzTGlKZhlXABChBoGspSCyVaDh0jepyJwBEtgJ30tYtqyiVkh2ik43uemoGaG0uNpper6MbTLzRwTj9-MW7K70KfzWTpJKCZ4H3W4EY_kyQRj24ZKHvjYcwJU04F4pUNZ3Rt0_Q6zDF3PUtVVPCRUXvqZXpQTvfhZzXzqJ6yQRmjFdq1ip3UCvwkIvMf965fP2IP9rB59XC4OzOgDcPB3M3kf-GyMC7LWCSNX0Xjbcu3XO1rLBQ84Q_bDgbQ0oRujuEYD2bUs-m1LMpM3v8hLVuNLMfcrWu3xHxD-Z84b0
CODEN DICAD2
CitedBy_id crossref_primary_10_1007_s00125_018_4567_5
crossref_primary_10_2337_dc17_1954
crossref_primary_10_3389_fendo_2019_00855
crossref_primary_10_1053_j_ajkd_2020_08_003
crossref_primary_10_1016_j_ekir_2016_12_003
crossref_primary_10_1038_s41440_023_01507_4
crossref_primary_10_2337_dc18_1320
crossref_primary_10_3389_fendo_2022_825950
crossref_primary_10_2478_dine_2022_0001
crossref_primary_10_1007_s11892_017_0854_7
crossref_primary_10_1007_s00467_014_2796_5
crossref_primary_10_1177_1479164115610247
crossref_primary_10_2215_CJN_03700417
crossref_primary_10_1186_s40001_021_00612_9
crossref_primary_10_1111_jdi_12533
crossref_primary_10_30682_ildia1903i
crossref_primary_10_3233_JAD_180498
crossref_primary_10_1007_s10157_020_01935_3
crossref_primary_10_1038_s41598_024_61395_7
crossref_primary_10_1111_dom_15800
crossref_primary_10_1093_ckj_sfw112
crossref_primary_10_1111_dom_14158
crossref_primary_10_1007_s10157_024_02465_y
crossref_primary_10_1007_s40620_020_00797_y
crossref_primary_10_1016_j_nefro_2015_05_013
crossref_primary_10_1007_s40620_020_00905_y
crossref_primary_10_1007_s00125_018_4691_2
crossref_primary_10_1016_j_dsx_2018_11_014
crossref_primary_10_1097_MNH_0000000000000489
crossref_primary_10_1186_s13098_020_0516_9
crossref_primary_10_3390_diabetology5040030
crossref_primary_10_2147_DMSO_S390483
crossref_primary_10_1155_2021_1497449
crossref_primary_10_1007_s00467_021_05050_7
crossref_primary_10_1016_j_jtumed_2022_11_002
crossref_primary_10_3390_kidneydial2030036
crossref_primary_10_1111_imj_14334
crossref_primary_10_2337_db17_1043
crossref_primary_10_1016_j_jdiacomp_2019_02_005
crossref_primary_10_1007_s00592_014_0650_7
crossref_primary_10_1016_j_nefroe_2016_09_003
crossref_primary_10_1111_nep_12288
crossref_primary_10_3390_life13020343
crossref_primary_10_3390_biom13050752
crossref_primary_10_1016_j_med_2016_09_003
crossref_primary_10_1016_j_cqn_2015_11_001
crossref_primary_10_1007_s13410_022_01132_w
crossref_primary_10_1681_ASN_2019010064
crossref_primary_10_2337_dc22_1611
crossref_primary_10_3390_jcm12144625
crossref_primary_10_3389_fendo_2022_871272
crossref_primary_10_2217_bmm_2018_0359
crossref_primary_10_3390_ijms21124239
crossref_primary_10_3389_fendo_2018_00225
crossref_primary_10_1007_s10238_024_01494_x
crossref_primary_10_1016_j_jacasi_2022_08_008
crossref_primary_10_3390_ijms232112863
crossref_primary_10_1016_j_jnma_2018_06_003
crossref_primary_10_1007_s40292_014_0067_y
crossref_primary_10_1016_j_nefroe_2021_11_009
crossref_primary_10_1016_j_nefro_2016_06_006
crossref_primary_10_2337_dc19_2049
crossref_primary_10_1080_0886022X_2022_2118067
crossref_primary_10_3390_life13041061
crossref_primary_10_1093_ndt_gfw417
crossref_primary_10_3390_ijms231810882
crossref_primary_10_1016_j_semnephrol_2016_08_001
crossref_primary_10_1111_jdi_14059
crossref_primary_10_1159_000485781
crossref_primary_10_1016_j_ekir_2021_06_001
crossref_primary_10_3389_fendo_2021_761386
crossref_primary_10_1007_s10157_020_01881_0
crossref_primary_10_1016_j_metabol_2021_154890
crossref_primary_10_5049_EBP_2022_20_2_39
crossref_primary_10_1080_13543784_2016_1196184
crossref_primary_10_1177_20420188211049615
crossref_primary_10_1371_journal_pone_0190923
crossref_primary_10_1038_nrneph_2015_173
crossref_primary_10_1007_s11892_015_0612_7
crossref_primary_10_1007_s10157_016_1290_8
crossref_primary_10_1002_cpdd_320
crossref_primary_10_1016_j_ejim_2016_02_012
crossref_primary_10_1016_j_disamonth_2024_101848
crossref_primary_10_1152_ajprenal_00415_2016
crossref_primary_10_2337_dci19_0030
crossref_primary_10_3390_jcm9093006
crossref_primary_10_2337_dbi20_0040
crossref_primary_10_1016_j_numecd_2020_09_013
crossref_primary_10_1016_j_jdiacomp_2018_09_019
crossref_primary_10_1136_bmjdrc_2014_000029
crossref_primary_10_1111_1753_0407_13150
crossref_primary_10_1016_j_diabres_2018_04_026
crossref_primary_10_22159_ajpcr_2022_v15i5_45053
crossref_primary_10_3390_ijms22189985
crossref_primary_10_1007_s40620_019_00650_x
crossref_primary_10_1007_s10157_017_1467_9
crossref_primary_10_1016_j_bspc_2023_104625
crossref_primary_10_20517_2574_1209_2024_21
crossref_primary_10_5483_BMBRep_2020_53_2_114
crossref_primary_10_17925_EE_2022_18_2_102
crossref_primary_10_1155_2018_7530923
crossref_primary_10_1093_hmg_ddac290
crossref_primary_10_1038_s41401_023_01106_6
crossref_primary_10_1016_j_nefroe_2015_05_003
crossref_primary_10_1038_s41598_019_38646_z
crossref_primary_10_1155_2019_5063089
crossref_primary_10_1016_j_nefroe_2016_11_013
crossref_primary_10_1371_journal_pone_0109641
crossref_primary_10_2174_1573399818666220328145046
crossref_primary_10_26442_terarkh201890104_98
crossref_primary_10_1007_s11684_017_0542_7
crossref_primary_10_1007_s10157_023_02433_y
crossref_primary_10_2337_dc21_1081
crossref_primary_10_1038_nrneph_2014_74
crossref_primary_10_1111_dom_14007
crossref_primary_10_3389_fendo_2022_1077929
crossref_primary_10_3390_jcm4061325
crossref_primary_10_1186_s12902_021_00769_8
crossref_primary_10_1097_MD_0000000000002804
crossref_primary_10_12688_f1000research_8005_1
crossref_primary_10_2337_dc21_1085
crossref_primary_10_1007_s13410_019_00751_0
crossref_primary_10_1016_j_numecd_2019_07_017
crossref_primary_10_1053_j_ackd_2014_03_007
crossref_primary_10_1155_2017_8637138
crossref_primary_10_1136_jim_2017_000556
crossref_primary_10_1016_j_diabres_2025_112104
crossref_primary_10_1159_000515163
crossref_primary_10_1007_s00592_018_1128_9
crossref_primary_10_1016_j_nefro_2016_03_025
crossref_primary_10_1038_ki_2014_98
crossref_primary_10_1038_s41581_021_00462_y
crossref_primary_10_36290_int_2018_049
crossref_primary_10_1136_bmjopen_2018_021655
crossref_primary_10_3390_vaccines12090972
crossref_primary_10_1136_bmjdrc_2024_004115
crossref_primary_10_1016_j_ekir_2019_06_005
crossref_primary_10_1038_nrendo_2013_184
crossref_primary_10_3390_cimb46120816
crossref_primary_10_1111_dme_14313
crossref_primary_10_3389_fendo_2023_1184190
crossref_primary_10_2174_1573399818666220426091238
crossref_primary_10_4239_wjd_v14_i10_1450
crossref_primary_10_3389_fphys_2020_578799
crossref_primary_10_1177_1479164121992524
crossref_primary_10_1002_dmrr_3556
crossref_primary_10_22141_2224_0721_17_2_2021_230565
crossref_primary_10_2337_dc15_0641
crossref_primary_10_3390_jcm13020348
crossref_primary_10_4239_wjd_v10_i11_517
crossref_primary_10_1016_j_lpm_2022_104159
crossref_primary_10_1111_dme_12535
crossref_primary_10_1007_s11560_014_0953_2
crossref_primary_10_1016_j_cellsig_2024_111451
crossref_primary_10_1016_j_nefro_2021_01_003
crossref_primary_10_13181_mji_v25i1_1329
crossref_primary_10_1007_s12020_022_03094_9
crossref_primary_10_1053_j_ajkd_2018_06_033
crossref_primary_10_24884_1561_6274_2018_22_5_31_38
crossref_primary_10_1186_s12933_023_02065_2
crossref_primary_10_3390_medicina57090868
crossref_primary_10_1007_s40620_014_0044_5
crossref_primary_10_1210_jc_2017_00930
crossref_primary_10_34067_KID_0000000000000248
crossref_primary_10_1007_s40620_024_01981_0
crossref_primary_10_1016_j_soard_2019_05_002
crossref_primary_10_1111_jcpt_12361
Cites_doi 10.1038/nrneph.2010.96
10.1016/j.diabres.2012.03.016
10.2337/diacare.27.1.195
10.1007/s001250050616
10.2337/diab.43.8.1046
10.2337/diabetes.54.5.1487
10.2337/diabetes.49.3.476
10.1007/s001250050628
10.1056/NEJM198904133201503
10.2337/dc09-1098
10.1056/NEJM198402093100605
10.2337/dc05-1788
10.1681/ASN.2010010010
10.1093/ndt/gfn351
10.1681/ASN.V381458
10.2337/diabetes.49.9.1399
10.2337/diab.43.5.649
10.1016/S0344-0338(80)80051-3
10.5858/133.2.224
10.2337/db05-1620
10.1046/j.1523-1755.1999.00721.x
10.1001/jama.289.24.3273
10.1038/ki.1992.118
10.2337/diabetes.52.4.1036
10.1016/S0344-0338(11)80780-6
10.1038/ki.1990.236
10.1172/JCI111523
ContentType Journal Article
Copyright 2014 INIST-CNRS
COPYRIGHT 2013 American Diabetes Association
Copyright American Diabetes Association Nov 2013
2013 by the American Diabetes Association. 2013
Copyright_xml – notice: 2014 INIST-CNRS
– notice: COPYRIGHT 2013 American Diabetes Association
– notice: Copyright American Diabetes Association Nov 2013
– notice: 2013 by the American Diabetes Association. 2013
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
5PM
DOI 10.2337/dc12-2572
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-5548
EndPage 3626
ExternalDocumentID PMC3816854
3113667081
A350334694
23835690
27860598
10_2337_dc12_2572
Genre Research Support, Non-U.S. Gov't
Journal Article
Feature
GroupedDBID ---
-ET
..I
.XZ
08P
0R~
18M
29F
2WC
4.4
53G
5GY
5RE
5RS
5VS
6PF
7RV
7X7
8C1
8FH
8G5
8R4
8R5
AAFWJ
AAIKC
AAKAS
AAMNW
AAWTL
AAYEP
AAYXX
ABOCM
ABPPZ
ACGFO
ACGOD
ADBBV
ADZCM
AEGXH
AENEX
AERZD
AFOSN
AFRAH
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AN0
ATCPS
BAWUL
BENPR
BHPHI
BPHCQ
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EDB
EJD
EMOBN
EX3
F5P
FYUFA
GUQSH
GX1
H13
HCIFZ
HZ~
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
ITC
KQ8
L7B
M0K
M0R
M0T
M2O
M2P
M5~
O5R
O5S
O9-
OK1
OVD
P2P
PCD
Q2X
RHI
SV3
TDI
TEORI
TR2
TWZ
VVN
W8F
WH7
WOQ
WOW
YHG
YOC
~KM
.55
.GJ
3O-
41~
7X2
88E
88I
8AF
8AO
8F7
8FE
8FI
8FJ
AAQOH
AAQQT
AAYJJ
ABUWG
AFFNX
AFKRA
AI.
AQUVI
AZQEC
BCR
BCU
BEC
BKEYQ
BKNYI
BLC
BNQBC
BVXVI
C1A
CCPQU
DWQXO
GNUQQ
HMCUK
IQODW
J5H
K9-
M1P
M2Q
N4W
NAPCQ
PEA
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
S0X
SJFOW
UKHRP
VH1
WHG
X7M
ZCG
ZGI
ZXP
3V.
CGR
CUY
CVF
ECM
EIF
IGG
NPM
RHF
VXZ
K9.
7X8
5PM
ID FETCH-LOGICAL-c538t-c86824e73cbda16ab36e35e951efd2e80895b4efb9f238ee18d50f8c7d3622883
ISSN 0149-5992
1935-5548
IngestDate Thu Aug 21 18:09:58 EDT 2025
Fri Jul 11 02:19:15 EDT 2025
Mon Jun 30 16:46:51 EDT 2025
Tue Jun 17 20:16:17 EDT 2025
Thu Jun 12 23:49:50 EDT 2025
Tue Jun 10 20:44:38 EDT 2025
Wed Feb 19 01:53:55 EST 2025
Mon Jul 21 09:12:23 EDT 2025
Tue Jul 01 04:11:37 EDT 2025
Thu Apr 24 23:01:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Endocrinopathy
Type 2 diabetes
Human
Kidney disease
Urine
Urinary system disease
Renal function
Nutrition
Albumin
Patient
Metabolic diseases
Kidney
Concomitant disease
Urinary system
Diabetic nephropathy
Endocrinology
Language English
License CC BY 4.0
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c538t-c86824e73cbda16ab36e35e951efd2e80895b4efb9f238ee18d50f8c7d3622883
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3816854
PMID 23835690
PQID 1447214562
PQPubID 47715
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3816854
proquest_miscellaneous_1445916724
proquest_journals_1447214562
gale_infotracmisc_A350334694
gale_infotracgeneralonefile_A350334694
gale_infotracacademiconefile_A350334694
pubmed_primary_23835690
pascalfrancis_primary_27860598
crossref_primary_10_2337_dc12_2572
crossref_citationtrail_10_2337_dc12_2572
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-11-01
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: 2013-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: Alexandria
PublicationTitle Diabetes care
PublicationTitleAlternate Diabetes Care
PublicationYear 2013
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Nosadini (2022031302174905200_B12) 2000; 49
Parving (2022031302174905200_B17) 1992; 41
Retnakaran (2022031302174905200_B6) 2006; 55
Bohle (2022031302174905200_B21) 1991; 187
Mogensen (2022031302174905200_B1) 1984; 310
Waldherr (2022031302174905200_B15) 1992; 37
Gambara (2022031302174905200_B18) 1993; 3
Gilbert (2022031302174905200_B23) 1999; 56
Tervaert (2022031302174905200_B26) 2010; 21
Mauer (2022031302174905200_B10) 1984; 74
Richards (2022031302174905200_B19) 1992; 7
Chavers (2022031302174905200_B2) 1989; 320
MacIsaac (2022031302174905200_B13) 2006; 29
Kramer (2022031302174905200_B7) 2003; 289
Fioretto (2022031302174905200_B11) 1996; 39
Bader (2022031302174905200_B22) 1980; 167
Olsen (2022031302174905200_B16) 1996; 39
Caramori (2022031302174905200_B4) 2000; 49
Caramori (2022031302174905200_B9) 2003; 52
Yagil (2022031302174905200_B14) 2005; 54
Madaio (2022031302174905200_B25) 1990; 38
Oh (2022031302174905200_B28) 2012; 97
Tsalamandris (2022031302174905200_B3) 1994; 43
Molitch (2022031302174905200_B8) 2010; 33
Haas (2022031302174905200_B29) 2009; 133
MacIsaac (2022031302174905200_B5) 2004; 27
White (2022031302174905200_B20) 2008; 23
Taft (2022031302174905200_B24) 1994; 43
Fioretto (2022031302174905200_B27) 2010; 6
16801579 - Diabetes Care. 2006 Jul;29(7):1560-6
1638776 - Clin Nephrol. 1992 Jun;37(6):271-3
12663477 - Diabetes. 2003 Apr;52(4):1036-40
6690964 - N Engl J Med. 1984 Feb 9;310(6):356-60
2068008 - Pathol Res Pract. 1991 Mar;187(2-3):251-9
16731850 - Diabetes. 2006 Jun;55(6):1832-9
10868971 - Diabetes. 2000 Mar;49(3):476-84
19195966 - Arch Pathol Lab Med. 2009 Feb;133(2):224-32
2232496 - Kidney Int. 1990 Sep;38(3):529-43
10969821 - Diabetes. 2000 Sep;49(9):1399-408
8168641 - Diabetes. 1994 May;43(5):649-55
20413518 - Diabetes Care. 2010 Jul;33(7):1536-43
8960844 - Diabetologia. 1996 Dec;39(12):1569-76
1513098 - Kidney Int. 1992 Apr;41(4):758-62
15855337 - Diabetes. 2005 May;54(5):1487-96
14693989 - Diabetes Care. 2004 Jan;27(1):195-200
8960856 - Diabetologia. 1996 Dec;39(12):1638-45
2784542 - N Engl J Med. 1989 Apr 13;320(15):966-70
20167701 - J Am Soc Nephrol. 2010 Apr;21(4):556-63
12824208 - JAMA. 2003 Jun 25;289(24):3273-7
18558622 - Nephrol Dial Transplant. 2008 Nov;23(11):3539-45
6480821 - J Clin Invest. 1984 Oct;74(4):1143-55
7433232 - Pathol Res Pract. 1980;167(2-4):204-16
22521535 - Diabetes Res Clin Pract. 2012 Sep;97(3):418-24
8490117 - J Am Soc Nephrol. 1993 Feb;3(8):1458-66
10571771 - Kidney Int. 1999 Nov;56(5):1627-37
1321374 - Nephrol Dial Transplant. 1992;7(5):397-9
8039599 - Diabetes. 1994 Aug;43(8):1046-51
20736983 - Nat Rev Nephrol. 2010 Sep;6(9):508-10
References_xml – volume: 6
  start-page: 508
  year: 2010
  ident: 2022031302174905200_B27
  article-title: Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2010.96
– volume: 97
  start-page: 418
  year: 2012
  ident: 2022031302174905200_B28
  article-title: Clinical implications of pathologic diagnosis and classification for diabetic nephropathy
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2012.03.016
– volume: 27
  start-page: 195
  year: 2004
  ident: 2022031302174905200_B5
  article-title: Nonalbuminuric renal insufficiency in type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.1.195
– volume: 39
  start-page: 1569
  year: 1996
  ident: 2022031302174905200_B11
  article-title: Patterns of renal injury in NIDDM patients with microalbuminuria
  publication-title: Diabetologia
  doi: 10.1007/s001250050616
– volume: 37
  start-page: 271
  year: 1992
  ident: 2022031302174905200_B15
  article-title: How frequent is glomerulonephritis in diabetes mellitus type II?
  publication-title: Clin Nephrol
– volume: 43
  start-page: 1046
  year: 1994
  ident: 2022031302174905200_B24
  article-title: Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria
  publication-title: Diabetes
  doi: 10.2337/diab.43.8.1046
– volume: 54
  start-page: 1487
  year: 2005
  ident: 2022031302174905200_B14
  article-title: Nonproteinuric diabetes-associated nephropathy in the Cohen rat model of type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.5.1487
– volume: 49
  start-page: 476
  year: 2000
  ident: 2022031302174905200_B12
  article-title: Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate
  publication-title: Diabetes
  doi: 10.2337/diabetes.49.3.476
– volume: 39
  start-page: 1638
  year: 1996
  ident: 2022031302174905200_B16
  article-title: How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature
  publication-title: Diabetologia
  doi: 10.1007/s001250050628
– volume: 7
  start-page: 397
  year: 1992
  ident: 2022031302174905200_B19
  article-title: Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus
  publication-title: Nephrol Dial Transplant
– volume: 320
  start-page: 966
  year: 1989
  ident: 2022031302174905200_B2
  article-title: Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198904133201503
– volume: 33
  start-page: 1536
  year: 2010
  ident: 2022031302174905200_B8
  article-title: Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study
  publication-title: Diabetes Care
  doi: 10.2337/dc09-1098
– volume: 310
  start-page: 356
  year: 1984
  ident: 2022031302174905200_B1
  article-title: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes
  publication-title: N Engl J Med
  doi: 10.1056/NEJM198402093100605
– volume: 29
  start-page: 1560
  year: 2006
  ident: 2022031302174905200_B13
  article-title: Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?
  publication-title: Diabetes Care
  doi: 10.2337/dc05-1788
– volume: 21
  start-page: 556
  year: 2010
  ident: 2022031302174905200_B26
  article-title: Pathologic classification of diabetic nephropathy
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2010010010
– volume: 23
  start-page: 3539
  year: 2008
  ident: 2022031302174905200_B20
  article-title: Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfn351
– volume: 3
  start-page: 1458
  year: 1993
  ident: 2022031302174905200_B18
  article-title: Heterogeneous nature of renal lesions in type II diabetes
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.V381458
– volume: 49
  start-page: 1399
  year: 2000
  ident: 2022031302174905200_B4
  article-title: The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
  publication-title: Diabetes
  doi: 10.2337/diabetes.49.9.1399
– volume: 43
  start-page: 649
  year: 1994
  ident: 2022031302174905200_B3
  article-title: Progressive decline in renal function in diabetic patients with and without albuminuria
  publication-title: Diabetes
  doi: 10.2337/diab.43.5.649
– volume: 167
  start-page: 204
  year: 1980
  ident: 2022031302174905200_B22
  article-title: Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters
  publication-title: Pathol Res Pract
  doi: 10.1016/S0344-0338(80)80051-3
– volume: 133
  start-page: 224
  year: 2009
  ident: 2022031302174905200_B29
  article-title: Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/133.2.224
– volume: 55
  start-page: 1832
  year: 2006
  ident: 2022031302174905200_B6
  article-title: Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74
  publication-title: Diabetes
  doi: 10.2337/db05-1620
– volume: 56
  start-page: 1627
  year: 1999
  ident: 2022031302174905200_B23
  article-title: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.1999.00721.x
– volume: 289
  start-page: 3273
  year: 2003
  ident: 2022031302174905200_B7
  article-title: Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus
  publication-title: JAMA
  doi: 10.1001/jama.289.24.3273
– volume: 41
  start-page: 758
  year: 1992
  ident: 2022031302174905200_B17
  article-title: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
  publication-title: Kidney Int
  doi: 10.1038/ki.1992.118
– volume: 52
  start-page: 1036
  year: 2003
  ident: 2022031302174905200_B9
  article-title: Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions
  publication-title: Diabetes
  doi: 10.2337/diabetes.52.4.1036
– volume: 187
  start-page: 251
  year: 1991
  ident: 2022031302174905200_B21
  article-title: The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis
  publication-title: Pathol Res Pract
  doi: 10.1016/S0344-0338(11)80780-6
– volume: 38
  start-page: 529
  year: 1990
  ident: 2022031302174905200_B25
  article-title: Renal biopsy
  publication-title: Kidney Int
  doi: 10.1038/ki.1990.236
– volume: 74
  start-page: 1143
  year: 1984
  ident: 2022031302174905200_B10
  article-title: Structural-functional relationships in diabetic nephropathy
  publication-title: J Clin Invest
  doi: 10.1172/JCI111523
– reference: 10571771 - Kidney Int. 1999 Nov;56(5):1627-37
– reference: 10969821 - Diabetes. 2000 Sep;49(9):1399-408
– reference: 8168641 - Diabetes. 1994 May;43(5):649-55
– reference: 6480821 - J Clin Invest. 1984 Oct;74(4):1143-55
– reference: 2232496 - Kidney Int. 1990 Sep;38(3):529-43
– reference: 8490117 - J Am Soc Nephrol. 1993 Feb;3(8):1458-66
– reference: 8960856 - Diabetologia. 1996 Dec;39(12):1638-45
– reference: 16801579 - Diabetes Care. 2006 Jul;29(7):1560-6
– reference: 18558622 - Nephrol Dial Transplant. 2008 Nov;23(11):3539-45
– reference: 2784542 - N Engl J Med. 1989 Apr 13;320(15):966-70
– reference: 15855337 - Diabetes. 2005 May;54(5):1487-96
– reference: 1638776 - Clin Nephrol. 1992 Jun;37(6):271-3
– reference: 16731850 - Diabetes. 2006 Jun;55(6):1832-9
– reference: 6690964 - N Engl J Med. 1984 Feb 9;310(6):356-60
– reference: 12824208 - JAMA. 2003 Jun 25;289(24):3273-7
– reference: 2068008 - Pathol Res Pract. 1991 Mar;187(2-3):251-9
– reference: 20736983 - Nat Rev Nephrol. 2010 Sep;6(9):508-10
– reference: 7433232 - Pathol Res Pract. 1980;167(2-4):204-16
– reference: 22521535 - Diabetes Res Clin Pract. 2012 Sep;97(3):418-24
– reference: 12663477 - Diabetes. 2003 Apr;52(4):1036-40
– reference: 19195966 - Arch Pathol Lab Med. 2009 Feb;133(2):224-32
– reference: 20167701 - J Am Soc Nephrol. 2010 Apr;21(4):556-63
– reference: 20413518 - Diabetes Care. 2010 Jul;33(7):1536-43
– reference: 8960844 - Diabetologia. 1996 Dec;39(12):1569-76
– reference: 1321374 - Nephrol Dial Transplant. 1992;7(5):397-9
– reference: 14693989 - Diabetes Care. 2004 Jan;27(1):195-200
– reference: 8039599 - Diabetes. 1994 Aug;43(8):1046-51
– reference: 1513098 - Kidney Int. 1992 Apr;41(4):758-62
– reference: 10868971 - Diabetes. 2000 Mar;49(3):476-84
SSID ssj0004488
Score 2.5063126
Snippet The structural basis of normoalbuminuric renal insufficiency in patients with type 2 diabetes remains to be elucidated. We compared renal biopsy findings in...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 3620
SubjectTerms Aged
Albuminuria
Albuminuria - etiology
Albuminuria - pathology
Associated diseases and complications
Biological and medical sciences
Biopsy
Care and treatment
Complications and side effects
Demographic aspects
Diabetes
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - pathology
Diabetes. Impaired glucose tolerance
Diabetic Nephropathies - etiology
Diabetic Nephropathies - pathology
Diagnosis
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Female
Glomerular Filtration Rate
Humans
Kidney diseases
Kidney Glomerulus - pathology
Kidneys
Male
Medical sciences
Metabolic diseases
Nephrology. Urinary tract diseases
Original Research
Patients
Renal Insufficiency - etiology
Renal Insufficiency - pathology
Type 2 diabetes
Urinary system involvement in other diseases. Miscellaneous
Title Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function
URI https://www.ncbi.nlm.nih.gov/pubmed/23835690
https://www.proquest.com/docview/1447214562
https://www.proquest.com/docview/1445916724
https://pubmed.ncbi.nlm.nih.gov/PMC3816854
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA96gggifrt6HlFEBam2aZqPx8MPjpMTlD24t9Km6bncXffY233xr3cmTdN2KaK-lN12dja788tkZjIzIeRVDTo_0YWMMiV4xDOYc4VgOpK1Bh-olkWssDj56Js4OOaHJ9lJv4PvqkvW5Xvza7Ku5H-kCvdArlgl-w-SDUzhBrwG-cIVJAzXv5LxD9u05R6bdiNg0bxrwAZdupzjRYMNg9pmrIP3vpGqr2qbb0Vg3VYCaIgFpqWvHHtc-YL0vBn7qaPHxLFglJ9h3N7nitV9OPbQrjYXgwB8COqcWR9OPceUprAbsnLB9FHaog9LJKmvzwtA6vabwoC24dbFM3WUaT1SyG1HlA54yUC9wmobT-l9lrrOAZVJWAQ6iPWLW0g53E9xw5YLza-TGwx8Cjzu4uv3QWt57g4pDSNq21Ah5w-B78h48Uv47cviCqZT3Z6DMuWobOfbDgyY-V1yx3sedL-F0T1yzTb3yc0jn1vxgFw4NNGAJrpo6DaaKOCDDt93aKKIJopooox2aHLUHZqoQxPt0PSQHH_5PP94EPnDOCIDa-I6Mkooxq1MTVkViSjKVNg0s2Cg27piVsVKZyW3dalrsAKtTVSVxbUysgKh4ZHWj8hOs2zsE0KNkBUzWhluOS9Zqjn4vLWpksoKYQyfkbfdv5wb36keD0w5z8FjRYHkKJAcBTIjLwPpZdueZYroDYoqR8QAH1P4yhMYDTY_y3tozMjrEeVp2_p9inB3RAg62Ywe741QEcbGpBLg0Cj4fAeT3CuUK_DCucSDAwSM-EV4jKwxEbKxy42jycCjkwy-43GLqp55Cu6U0PGMyBHeAgG2kh8_aRY_XUt5TB9QGX_655_1jNzqp_ou2QFA2udgk6_LPTeXfgOpIOdz
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Renal+structure+in+normoalbuminuric+and+albuminuric+patients+with+Type+2+diabetes+and+impaired+renal+function&rft.jtitle=Diabetes+care&rft.au=Ekinci%2C+Elif+I&rft.au=Jerums%2C+George&rft.au=Skene%2C+Alison&rft.au=Crammer%2C+Paul&rft.date=2013-11-01&rft.pub=American+Diabetes+Association&rft.issn=0149-5992&rft.volume=36&rft.issue=11&rft.spage=3620&rft_id=info:doi/10.2337%2Fdc12-2572&rft.externalDocID=A350334694
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon